Global Milbexime Anthelmintic Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Milbexime Anthelmintic Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Similar to other macrolide antiparasitic drugs, milbexime acts as an agonist of GABA (γ-aminobutyric acid) neurotransmitter in nerve cells, and can also interact with gluten in nerve and muscle cells of invertebrates Amino acid-gated Cl-channel binding. In both cases, it blocks the parasite's nerve signaling, eventually paralyzing the parasite, causing the muscles to lose their ability to contract, stop feeding, and cause the parasite to die. Milbexime also affects the reproductive activity of some parasites by reducing oviposition or inducing abnormal egg production.
Milbexime Anthelmintic report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Milbexime Anthelmintic market is projected to reach US$ 938 million in 2029, increasing from US$ 628 million in 2022, with the CAGR of 5.9% during the period of 2024 to 2029. Demand from Cat and Dog are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Milbexime Anthelmintic industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Milbexime Anthelmintic key manufacturers include Elanco Animal Health, Boehringer Ingelheim Animal Health, Merck Animal Health, VIRBAC SA, Krka and Zhejiang Hisun Pharmaceutical Co., Ltd, etc. Elanco Animal Health, Boehringer Ingelheim Animal Health, Merck Animal Health are top 3 players and held % sales share in total in 2022.
Milbexime Anthelmintic can be divided into Single Ingredient and Compound Ingredients, etc. Single Ingredient is the mainstream product in the market, accounting for % sales share globally in 2022.
Milbexime Anthelmintic is widely used in various fields, such as Cat, Dog and Other,, etc. Cat provides greatest supports to the Milbexime Anthelmintic industry development. In 2022, global % sales of Milbexime Anthelmintic went into Cat filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Milbexime Anthelmintic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Elanco Animal Health
Boehringer Ingelheim Animal Health
Merck Animal Health
VIRBAC SA
Krka
Zhejiang Hisun Pharmaceutical Co., Ltd
Segment by Type
Single Ingredient
Compound Ingredients
Cat
Dog
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Milbexime Anthelmintic market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Milbexime Anthelmintic, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Milbexime Anthelmintic industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Milbexime Anthelmintic in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Milbexime Anthelmintic introduction, etc. Milbexime Anthelmintic Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Milbexime Anthelmintic market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Milbexime Anthelmintic report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Milbexime Anthelmintic market is projected to reach US$ 938 million in 2029, increasing from US$ 628 million in 2022, with the CAGR of 5.9% during the period of 2024 to 2029. Demand from Cat and Dog are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Milbexime Anthelmintic industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Milbexime Anthelmintic key manufacturers include Elanco Animal Health, Boehringer Ingelheim Animal Health, Merck Animal Health, VIRBAC SA, Krka and Zhejiang Hisun Pharmaceutical Co., Ltd, etc. Elanco Animal Health, Boehringer Ingelheim Animal Health, Merck Animal Health are top 3 players and held % sales share in total in 2022.
Milbexime Anthelmintic can be divided into Single Ingredient and Compound Ingredients, etc. Single Ingredient is the mainstream product in the market, accounting for % sales share globally in 2022.
Milbexime Anthelmintic is widely used in various fields, such as Cat, Dog and Other,, etc. Cat provides greatest supports to the Milbexime Anthelmintic industry development. In 2022, global % sales of Milbexime Anthelmintic went into Cat filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Milbexime Anthelmintic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Elanco Animal Health
Boehringer Ingelheim Animal Health
Merck Animal Health
VIRBAC SA
Krka
Zhejiang Hisun Pharmaceutical Co., Ltd
Segment by Type
Single Ingredient
Compound Ingredients
Segment by Application
Cat
Dog
Other
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Milbexime Anthelmintic market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Milbexime Anthelmintic, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Milbexime Anthelmintic industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Milbexime Anthelmintic in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Milbexime Anthelmintic introduction, etc. Milbexime Anthelmintic Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Milbexime Anthelmintic market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices